APTEVO BIOTHERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Oct 2025)
What this means for you
This application is over — abandoned 13 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90165952
- Mark type
- Stylized text
- Filed
- 08 Sept 2020
- Published for opposition
- 12 Jul 2022
- Abandoned
- 13 Oct 2025
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, immune system diseases and disorders, autoimmune system diseases, and blood disorders, none of the foregoing related to oncology
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields, none of the foregoing related to oncology
Owner
- APTEVO RESEARCH AND DEVELOPMENT LLC, Seattle, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, Seattle, WA, US
Prosecution history
- 13 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jul 2025 — SOU EXTENSION 5 GRANTED
- 04 Mar 2025 — SOU EXTENSION 5 FILED
- 01 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Aug 2024 — SOU EXTENSION 4 GRANTED
- 30 Aug 2024 — SOU EXTENSION 4 FILED
- 30 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2024 — SOU EXTENSION 3 GRANTED
- 06 Mar 2024 — SOU EXTENSION 3 FILED
- 06 Mar 2024 — SOU TEAS EXTENSION RECEIVED